粘多糖症IIIB型与胰岛素减肥:一个病例报告和小鼠的血液学相关性
Éliane Beauregard-Lacroix1, Patricia Dubot2, Alexey V Pshezhetsky2
1Medical Genetics Division, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.
Clinical genetics
|May 29, 2025
概括
粘多糖型IIIB (MPS IIIB) 或桑菲利普波综合征B是一种罕见的遗传性疾病. 这项研究建议在MPS IIIB患者中监测全血细胞计,因为观察到血液学异常.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 粘多糖症IIIB型 (MPS IIIB),或Sanfilippo综合征B,是一种溶酶体储存疾病,由受损的肝素硫酸盐降解引起.
- MPS IIIB通常表现为严重的神经衰退,发育回归和行为问题,以及其他系统性并发症.
研究的目的:
- 调查MPS IIIB与血液学异常,特别是泛细胞衰竭之间的潜在联系.
- 探索MPS IIIB和观察到的血清变化之间的病理生理关系.
主要方法:
- 一个患有MPS IIIB和慢性泛细胞衰竭的患者的病例报告.
- 在MPS IIIBNaglu-/-小鼠模型中进行血液学分析,以确定特定的血清变化.
主要成果:
- 该研究确定了第二个被诊断为MPS IIIB和慢性泛细胞衰竭的个人.
- 在MPS IIIBNaglu-/-小鼠中进行的血液学研究显示微细胞贫血和单细胞数量减少,但没有血小板缺血.
结论:
- 在MPS IIIB中血液学发现可能是疾病的次要因素,尽管确切的机制需要进一步阐明.
- 作为诊断为MPS IIIB的个体的临床监测的一部分,建议进行完整的血液细胞计数监测,因为它可能是一种不常见的临床特征.
相关概念视频
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type I Diabetes III: Clinical Manifestations
31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32
Hypoglycemia
34
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34


